[go: up one dir, main page]

NO970885D0 - Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider - Google Patents

Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider

Info

Publication number
NO970885D0
NO970885D0 NO970885A NO970885A NO970885D0 NO 970885 D0 NO970885 D0 NO 970885D0 NO 970885 A NO970885 A NO 970885A NO 970885 A NO970885 A NO 970885A NO 970885 D0 NO970885 D0 NO 970885D0
Authority
NO
Norway
Prior art keywords
ribonucleotides
splitting
compositions
methods
oligonucleotide conjugates
Prior art date
Application number
NO970885A
Other languages
English (en)
Other versions
NO970885L (no
Inventor
Dieter Huesken
Heinz Moser
Robert Haener
Jonathan Hall
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO970885D0 publication Critical patent/NO970885D0/no
Publication of NO970885L publication Critical patent/NO970885L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO970885A 1994-09-02 1997-02-27 Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider NO970885L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269494 1994-09-02
PCT/EP1995/003408 WO1996007667A1 (de) 1994-09-02 1995-08-30 Oligonukleotidkonjugate, zusammensetzungen und verfahren zur spaltung von ribonukleinsäuren

Publications (2)

Publication Number Publication Date
NO970885D0 true NO970885D0 (no) 1997-02-27
NO970885L NO970885L (no) 1997-04-25

Family

ID=4239485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970885A NO970885L (no) 1994-09-02 1997-02-27 Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider

Country Status (8)

Country Link
EP (1) EP0778845A1 (no)
JP (1) JPH10505353A (no)
AU (1) AU3519095A (no)
CA (1) CA2197785A1 (no)
FI (1) FI970696L (no)
HU (1) HUT77034A (no)
NO (1) NO970885L (no)
WO (1) WO1996007667A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
WO1998007733A1 (en) * 1996-08-20 1998-02-26 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
KR101040700B1 (ko) * 2006-11-16 2011-06-10 주식회사 엘지화학 테레프탈알데히드의 정제방법
NZ580457A (en) 2007-04-06 2012-03-30 Neurocrine Biosciences Inc Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CL2008000986A1 (es) 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis

Also Published As

Publication number Publication date
EP0778845A1 (de) 1997-06-18
FI970696A0 (fi) 1997-02-19
CA2197785A1 (en) 1996-03-14
JPH10505353A (ja) 1998-05-26
AU3519095A (en) 1996-03-27
WO1996007667A1 (de) 1996-03-14
HUT77034A (hu) 1998-03-02
FI970696L (fi) 1997-02-19
NO970885L (no) 1997-04-25

Similar Documents

Publication Publication Date Title
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DE69708120D1 (de) Laser-absorbierende, lichtbleichbare zusammensetzungen
IS1903B (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
ZA961291B (en) Naphthyl compounds, intermediates, compositions, and methods.
FI963692L (fi) Menetelmiä ja koostumuksia, jotka ovat käyttökelpoisia angiogeneesin inhibointiin
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
BR9708853A (pt) Composição em barra
DE69738511D1 (de) Datensendeverfahren
NO951447D0 (no) Organoaluminoksyprodukt, fremstilling og anvendelse
NO20013237D0 (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
FI971861L (fi) Puristuskoostumus, valmistusmenetelmä, puristusmenetelmä ja puristustuotteita
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
FI972264L (fi) Betaiinituote, menetelmä sen valmistamiseksi, ja sen käyttö
BR9708736A (pt) Composição em barra
BR9709701A (pt) Composição em barra
NO970885D0 (no) Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
NO20001288D0 (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel
NO970136D0 (no) Granulös formulering inneholder mikroorganismer, fremgangsmåte for fremstilling og anvendelse derav
BRPI9703099B8 (pt) derivado de carboidrato, e, composição farmacêutica
BR9708090A (pt) Composição em barra
NO20003268D0 (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
TR199700863A3 (tr) Paklitaksel hazirlama prosesi.